Here, we found the potential of new coumarin derivatives ZN014 and ZN015 for AD treatment by reducing Aβ aggregation, ROS, caspase-1, and AChE as well as promoting neurite outgrowth (Figure 2 and Figure 3) and TRKB signaling (Figure 4). Here, NTRK2 is linked to Alzheimer disease.